Indian experience of lenvatinib in radio-iodine refractory differentiated thyroid cancer.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.e18107
Abstract: e18107Background: Differentiated thyroid cancer (DTC) accounts for approximately 95% of thyroid carcinomas. Chemotherapy has very limited efficacy in metastatic Radioactive Iodine (RAI)-refractory ... read more here.
Keywords: experience lenvatinib; differentiated thyroid; thyroid cancer; iodine ... See more keywords
Real-world experience with Lenvatinib in the management of Hepatocellular Carcinoma: A single-center Indian experience.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.15_suppl.e16596
Abstract: e16596Background: Sorafenib has been the standard first line treatment for more than a decade in advanced Hepatocellular carcinoma (HCC) patients. Lenvatinib is a novel oral tyrosine kinase inhibit... read more here.
Keywords: hepatocellular carcinoma; real world; experience lenvatinib; world experience ... See more keywords